The Korean securities firms' promissory note market has entered a new phase. With Kiwoom Securities, Hana Securities, and Shinhan Investment & ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or ...

ORIC Pharmaceuticals (ORIC) on Monday announced operational highlights for 2025 and anticipated upcoming milestones. ORIC anticipates the following upcoming milestones: Rinzimetostat in mCRPC: 1Q 2026 ...

The IB ACIO exam city intimation slip 2025 helps candidates prepare in advance. The Tier 1 exam will be held on 16, 17, and 18 September 2025, while the Tier 2 exam will be held on 11 January 2026.

Good day, and thank you for standing by. Welcome to the ORIC Enozertinib Program Update Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...

In every cycle, commercial real estate investors gravitate toward what feels safe. Familiar sectors, familiar markets, familiar strategies; the pattern itself is familiar. Yet comfort rarely produces ...

JPMorgan’s JPM investment banking (IB) business gained solid traction through the first nine months of 2025, signaling a strong recovery in global deal activity. The bank reported IB fees of $7.29 ...

Sequoia Middle School is introducing an advanced learning program for students beginning this school year. The Newbury Park campus has been named a candidate school for the International Baccalaureate ...

HOUSTON -- Complete response (CR) rates in relapsed/refractory NPM1-mutated acute myeloid leukemia (AML) doubled historical rates in a preliminary study of an investigational menin inhibitor. A pooled ...

Adjuvant chemotherapy is often recommended for patients with stage IB non-small cell lung cancer (NSCLC) who have high-risk disease features, explained researchers who presented a poster at the 2025 ...

- Higher drug exposure and favorable tolerability profile positions ASC30 oral once-daily tablet favorably compared to orforglipron. In the Phase Ib MAD study, ASC30 oral once-daily tablet was safe ...